Statera BioPharma (STU:7CB) Ending Cash Position : €0.51 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Ending Cash Position?

Statera BioPharma's Ending Cash Position for the quarter that ended in Sep. 2022 was €0.51 Mil.

Statera BioPharma's quarterly Ending Cash Position increased from Mar. 2022 (€0.14 Mil) to Jun. 2022 (€0.52 Mil) but then declined from Jun. 2022 (€0.52 Mil) to Sep. 2022 (€0.51 Mil).

Statera BioPharma's annual Ending Cash Position increased from Dec. 2019 (€0.00 Mil) to Dec. 2020 (€0.49 Mil) and increased from Dec. 2020 (€0.49 Mil) to Dec. 2021 (€6.06 Mil).

Statera BioPharma Ending Cash Position Historical Data

The historical data trend for Statera BioPharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Ending Cash Position Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

Ending Cash Position

0.49

6.06

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Ending Cash Position	Get a 7-Day Free Trial						12.08	6.06	0.14	0.52	0.51

Statera BioPharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Statera BioPharma's Ending Cash Position for the fiscal year that ended in Dec. 2021 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.526	+	5.532
	=	6.06

Statera BioPharma's Ending Cash Position for the quarter that ended in Sep. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.56	+	-0.049
	=	0.51

Statera BioPharma Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines